These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21280319)

  • 1. [Comparison of viremia formation between guinea-pigs infected with wild and attenuated (SA14-14-2) Japanese encephalitis viruses].
    Liu XY; Yu YX; Xu HS; Liang GD; Wang HY; Jia LL; Dong GM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Oct; 24(5):343-5. PubMed ID: 21280319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Construction of infectious Japanese encephalitis virus clone based on the cDNA template of the attenuated live vaccine production strain SA14-14-2].
    Zeng M; Jia LL; Yu YX; Dong GM; Liu WX; Wang ZW; Li DF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):9-11. PubMed ID: 16201461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo.
    Yun SI; Song BH; Polejaeva IA; Davies CJ; White KL; Lee YM
    J Gen Virol; 2016 Oct; 97(10):2575-2591. PubMed ID: 27498826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic and vaccine strains of Japanese encephalitis virus elicit different levels of human macrophage effector functions.
    Sooryanarain H; Sapkal GN; Gore MM
    Arch Virol; 2012 Oct; 157(10):1905-18. PubMed ID: 22729616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection.
    Wang J; Li X; Gu J; Fan Y; Zhao P; Cao R; Chen P
    Infect Genet Evol; 2015 Dec; 36():116-125. PubMed ID: 26384477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
    Gromowski GD; Firestone CY; Whitehead SS
    J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
    Yang H; Fan F; Liu L; Liu J; Sun Y; Xie A; Shi X; Liu L; Yu Y; Li Y; Ge Y; Zeng X; Yang H
    Vaccine; 2020 Mar; 38(11):2636-2642. PubMed ID: 32044162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japanese Encephalitis Vaccines: WHO position paper – February 2015.
    Wkly Epidemiol Rec; 2015 Feb; 90(9):69-87. PubMed ID: 25726573
    [No Abstract]   [Full Text] [Related]  

  • 10. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.
    Monath TP; Arroyo J; Levenbook I; Zhang ZX; Catalan J; Draper K; Guirakhoo F
    J Virol; 2002 Feb; 76(4):1932-43. PubMed ID: 11799188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research on Culex tritaeniorhynchus and Culex pipiens quinquefasciatus intrathoracically infected with attenuated Japanese encephalitis virus SA14-14-2 vaccine strain].
    Zhang YZ; Zhang HL; Yu YX; Feng Y; Dong GM; Yang WH; Jia LL; Yao YF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec; 19(4):344-6. PubMed ID: 16415992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
    Yu Y
    Vaccine; 2010 May; 28(21):3635-41. PubMed ID: 20226891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain.
    Yang J; Yang H; Li Z; Wang W; Lin H; Liu L; Ni Q; Liu X; Zeng X; Wu Y; Li Y
    Viruses; 2017 Jan; 9(1):. PubMed ID: 28117725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Japanese encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: impact of the structural protein region on virulence.
    de Wispelaere M; Frenkiel MP; Desprès P
    J Virol; 2015 Jun; 89(11):5862-75. PubMed ID: 25787283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-type JE viruses.
    Jia L; Wang Z; Yu Y
    Chin Med J (Engl); 2003 Jun; 116(6):941-3. PubMed ID: 12877812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in haemagglutination activity and electrophoretic mobility of E protein between the parent SA14 and attenuated vaccine SA14-14-2 strains of Japanese encephalitis virus.
    Lee T; Komiya T; Watanabe K; Aizawa C; Hashimoto H
    Acta Virol; 1995 Apr; 39(2):109-11. PubMed ID: 7676935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field experiments on live attenuated Japanese encephalitis virus vaccine for swine.
    Ueba N; Kimura T; Nakajima S; Kurimura T; Kitaura T
    Biken J; 1978 Sep; 21(3):95-103. PubMed ID: 219844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of attenuated Japanese encephalitis live vaccine strain ML-17.
    Shah PS; Tanaka M; Khan AH; Mathenge EG; Fuke I; Takagi M; Igarashi A; Morita K
    Vaccine; 2006 Jan; 24(4):402-11. PubMed ID: 16303214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of change in viral titers under different conditions in cultured cells persistently-infected with Japanese encephalitis virus].
    Xu KS; Li Q; Zhou X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):147-9. PubMed ID: 17653319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus.
    Lee E; Lobigs M
    J Virol; 2002 May; 76(10):4901-11. PubMed ID: 11967307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.